Market Currents
BioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for...
-
Monday, November 28, 2011, 2:25 PM ETBioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for the expansion of its manufacturing facility in Novato, CA. The facility will support will the company's enzyme replacement therapy portfolio, and provide up to $1B in revenue.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
